Clinical application value of flow cytometry in detection of related cytokines at the early stage of influenza
10.3969/j.issn.1673-4130.2017.24.014
- VernacularTitle:流行性感冒发病初期利用流式细胞仪检测相关细胞因子的临床应用价值探讨
- Author:
Juan LI
1
;
Miaomiao ZHAO
;
Xueying MA
;
Pei QU
;
Xiang ZHANG
;
Jie GUO
;
Yu ZHOU
;
Shujing SONG
Author Information
1. 首都医科大学附属北京地坛医院检验科
- Keywords:
influenza A;
multiple bead arrays;
cytokines;
clinical value
- From:
International Journal of Laboratory Medicine
2017;38(24):3396-3397,3400
- CountryChina
- Language:Chinese
-
Abstract:
Objective To establish a clinical cytokine test method based on flow multiple microarray technology,and discuss its clinical significance by observing the change of cytokines level in the early stage of influenza.Methods 54 cases of influenza A virus positive and 20 cases of influenza A virus negative influenza like patients were selected as influenza group.Among them,influenza A virus positive patients were divided into mild group and severe group,influenza A virus negative influenza like patients were as neg-ative group.In addition,35 healthy people were selected as the control group,and the cytokine of all the whole blood samples was detected and statistically analyzed.Results Interleukin-6(IL-6),interleukin-21(IL-21),interleukin-12p70(IL-12p70),interleukin-1 β(IL-1 β)and interleukin-10(IL-10),chemokine-10(IP-10),interleukin-2(IL-2),monocyte chemoattractant protein-1(MCP-1)lev-els were significantly higher in the patients with early onset of influenza,and the difference was statistically significant(P<0.05). The difference of interferon-γ(IFN-γ)between the influenza group and the control group was not statistically significant(P> 0. 05).The levels of IL-6 and IP-10 in the severe group were higher than that of the mild group and the negative group,and the differ-ence was statistically significant(P<0.05).Conclusion IL-6,IL-21,IL-12p70,IL-1 beta,IL-10,IP-10,IL-2 and MCP-1 levels can be used as clinical biological evaluation indicators of patients with fever,of which IL-6 and IP-10 can be used as important indicators for disease progression assessment.
